ARMP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Armata Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 5.53 USD 4.73% Market Closed

Market Cap: $203m

A	Armata Pharmaceuticals Inc AMEX:ARMP	US
	APG SGA SA SIX:APGN	CH
	Armata Pharmaceuticals Inc F:TG1N	US

Profitability Summary

Armata Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-734%

Negative 3Y Average Operating Margin

-806%

Operating Margin is Increasing

-958% > -734%

Negative Net Margin

-3 467%

Negative 3Y Average Net Margin

-1 780%

Declining Net Margin

-886% > -3 467%

Negative Free Cash Flow Margin

-465%

Negative 3Y Average Free Cash Flow Margin

-800%

Free Cash Flow Margin is Increasing

-1 283% > -465%

Exceptional ROE

128%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-52%

Declining ROIC

-57% > -58%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.